Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?
J Pediatr
.
1999 Oct;135(4):526-8.
doi: 10.1016/s0022-3476(99)70180-0.
Author
B Schmidt
1
Affiliation
1
Departments of Pediatrics and Clinical Epidemiology & Biostatistics, McMaster University Hamilton, Ontario L8N 3Z5 Canada.
PMID:
10518091
DOI:
10.1016/s0022-3476(99)70180-0
No abstract available
MeSH terms
Apnea / drug therapy*
Humans
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Xanthines / adverse effects
Xanthines / therapeutic use*
Substances
Xanthines
methylxanthine